Your browser doesn't support javascript.
loading
Phase I trial of the androgen receptor modulator CR1447 in breast cancer patients.
Zweifel, Martin; Thürlimann, Beat; Riniker, Salome; Weder, Patrik; von Moos, Roger; Pagani, Olivia; Bigler, Martin; Rothgiesser, Karin M; Pilop, Christiane; Hawle, Hanne; Brauchli, Peter; Tapia, Coya; Schoenfeld, Wolfgang; Sessa, Cristiana.
Afiliação
  • Zweifel M; Department of Medical OncologyUniversity Hospital Bern, Bern, Switzerland martin.zweifel@insel.ch.
  • Thürlimann B; Breast Centre St. GallenKantonsspital St. Gallen, St. Gallen, Switzerland.
  • Riniker S; Breast Centre St. GallenKantonsspital St. Gallen, St. Gallen, Switzerland.
  • Weder P; Breast Centre St. GallenKantonsspital St. Gallen, St. Gallen, Switzerland.
  • von Moos R; Kantonsspital GraubündenChur, Switzerland.
  • Pagani O; Istituto Oncologico della Svizzera ItalianaBellinzona, Switzerland.
  • Bigler M; SAKK Coordinating CentreBern, Switzerland.
  • Rothgiesser KM; SAKK Coordinating CentreBern, Switzerland.
  • Pilop C; SAKK Coordinating CentreBern, Switzerland.
  • Hawle H; SAKK Coordinating CentreBern, Switzerland.
  • Brauchli P; SAKK Coordinating CentreBern, Switzerland.
  • Tapia C; Institute of PathologyUniversity of Bern, Bern, Switzerland.
  • Schoenfeld W; CURADIS GmbHErlangen, Germany.
  • Sessa C; Istituto Oncologico della Svizzera ItalianaBellinzona, Switzerland.
Endocr Connect ; 6(7): 549-556, 2017 Oct.
Article em En | MEDLINE | ID: mdl-28814476

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Endocr Connect Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Endocr Connect Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Suíça